Literature DB >> 32238788

Changes in prevalence and perception of complementary and alternative medicine use in Korean inflammatory bowel disease patients: results of an 8-year follow-up survey.

Sun-Ho Lee1, Kiju Chang1, Ki Seok Seo2, Yun Kyung Cho1, Eun Mi Song1, Sung Wook Hwang1, Dong-Hoon Yang1, Byong Duk Ye1, Jeong-Sik Byeon1, Seung-Jae Myung1, Suk-Kyun Yang1, Sang Hyoung Park1.   

Abstract

BACKGROUND/AIMS: The use of complementary and alternative medicine (CAM) is a global phenomenon, including inflammatory bowel disease (IBD) patients. We aimed to assess the change in prevalence and patterns of CAM use, and attitudes towards CAM over an 8-year time interval (2006 vs. 2014) among IBD patients in Korea.
METHODS: A total of 221 IBD patients (CD=142, UC=79) were asked to complete a questionnaire regarding CAM at two time points: at enrollment (2006) and 8 years later (2014/2015).
RESULTS: The proportion of patients ever using CAM increased significantly from 60.2% in 2006 to 79.6% in 2014 (P<0.001), while the proportion of current CAM users increased slightly (35.7% to 38.0%, P=0.635); 21.7% used CAM consistently at both time points. The proportion of patients who felt CAM was less effective (P<0.001) and more expensive (P=0.04) than conventional treatments increased over time. Also, the proportion among ever CAM users who perceived a positive effect from CAM significantly decreased in 2014 compared to 2006 (P=0.004). Higher education (adjusted odds ratio [aOR], 2.10), prior side effects to conventional therapies (aOR, 2.23), and prior use of corticosteroids (aOR, 2.51) were associated with CAM use. Interestingly, use of CAM before IBD diagnosis (aOR, 2.73) was significantly associated with consistent CAM use.
CONCLUSIONS: Although the attitudes toward CAM have become less favorable, the majority of IBD patients have experienced CAM with an overall increase of current CAM users over time. Moreover, more than half of current CAM users used CAM consistently over time.

Entities:  

Keywords:  Colitis, ulcerative; Complementary and alternative medicine; Crohn disease; Inflammatory bowel disease

Year:  2020        PMID: 32238788     DOI: 10.5217/ir.2019.00115

Source DB:  PubMed          Journal:  Intest Res        ISSN: 1598-9100


  3 in total

1.  Complementary and alternative medicine in patients with inflammatory bowel disease: hype or evidence?

Authors:  Jae Myung Cha
Journal:  Intest Res       Date:  2020-04-20

2.  Perspectives of East Asian patients and physicians on complementary and alternative medicine use for inflammatory bowel disease: results of a cross-sectional, multinational study.

Authors:  Eun Soo Kim; Chung Hyun Tae; Sung-Ae Jung; Dong Il Park; Jong Pil Im; Chang Soo Eun; Hyuk Yoon; Byung Ik Jang; Haruhiko Ogata; Kayoko Fukuhara; Fumihito Hirai; Kazuo Ohtsuka; Jing Liu; Qian Cao
Journal:  Intest Res       Date:  2022-04-29

3.  Improvement in Medication Adherence after Pharmacist Intervention Is Associated with Favorable Clinical Outcomes in Patients with Ulcerative Colitis.

Authors:  Jae Song Kim; Min Jung Geum; Eun Sun Son; Yun Mi Yu; Jae Hee Cheon; Kyeng Hee Kwon
Journal:  Gut Liver       Date:  2022-02-11       Impact factor: 4.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.